Why the cost difference exists Eli Lilly spent billions developing tirzepatide through clinical trials, regulatory submissions, and manufacturing infrastructure
Personalized medical advice is necessary to determine if one drug is a better fit than the other
GLP-1RAS AND DIABETIC RETINOPATHY The phenomenon of worsening diabetic retinopathy (DR), often termed rebound retinopathy, is a well-established, paradoxical retinal finding linked to improved blood glucose levels, typically observed 3 months to 3 years after intense glucose lowering
During sleep, cells repair DNA damage, build proteins, and regenerate tissues
Patients received an initial dose of either 1 mg, 2 mg, or 4 mg of retatrutide and subsequent doses of either 1 mg, 4 mg, 8 mg, or 12 mg, or they received a placebo throughout the 48 weeks of the study
(Compounders are required to follow regulations about manufacturing, but the drugs they produce are not FDA-approved.) Noorian, a former mechanical engineer, founded Empower Pharmacy in 2009 after using a compounded medicine to treat his own low testosterone at age 24